KeyBanc notes that CMS issued an update on six new HCPCS codes for Obstructive Sleep Apnea -Hypoglossal Nerve Stimulation procedures, mapping the Inspire V specific new C-code at parity with HCPCS 64582, which the firm views as a “directionally positive update.” The firm keeps a Sector Weight rating on Inspire Medical (INSP) shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire reimbursement unchanged as CMS confirms APC 5465 mapping, says Stifel
- Inspire Medical price target lowered to $85 from $95 at Stifel
- Inspire Medical jumps after KeyBanc says CMS ‘appears ready’ to add C-codes
- Inspire Medical halted again for volatility after jumping 34% to $79.11
- Inspire Medical Systems trading resumes